Former Lonza biologics CSO joins Cobra board
Cobra Biologics says former Lonza biopharmaceutical science officer brings strategic insight, process development and manufacturing expertise.
Archives for October 22, 2012
DRAP sets up committee to solve price restructuring woes with CMOs
The Drug Regulatory Authority of Pakistan has set up a committee to resolve registration and licensing issues with local contract manufacturers.
News from AAPS
Low API and excipient volumes vital to win authorisation under EU PIP says EMA
Pharmas should use lower API and excipient volumes if seeking authorisation under the EU Paediatric Investigation Plan (PIP) says the EMA.
EMA wants to revise BVDV testing requirements for bovine serum
The EMA wants feedback on its plans to revise testing requirements for bovine serum used to manufacture biologics.
EMA publishes guidance on trial data publishing
The EMA has issued new guidance on the publication of clinical trial results as part of an effort to make such data publicly available.
News from AAPS
Xcelience plans EU clinical trial supply expansion after opening new US plant
Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
News from Heptares, Cerecor and Dyax Corp – People on the move
in-PharmaTechnologist.com presents its weekly round-up of career changes in the pharmaceutical industry, including news from Heptares, Cerecor and Dyax Corp.
Motion sickness chewing gum gives platform for active ingredient formulation – researchers
A medicated chewing gum prototype that combats motion sickness could give a platform to incorporate other active ingredients with objectionable tastes into gum.